Lupus, antiphospholipid syndrome and epilepsy: An update

Lupus

Volumn 26, Issue 1, 2017, Pages 3-5

  Rosati, A ^a   Guerrini, R ^a   Cimaz, R ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

antiphospholipid antibodies; autoantibodies; epilepsy; seizures; Systemic lupus erythematosus

Indexed keywords

BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; GLUTAMATE RECEPTOR; HLA DQB1 ANTIGEN; IMMUNOGLOBULIN FC FRAGMENT; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

AFRICAN AMERICAN; ANTIPHOSPHOLIPID SYNDROME; CAUCASIAN; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE DURATION; EPILEPSY; ETHNIC DIFFERENCE; FOCAL EPILEPSY; GENETIC POLYMORPHISM; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; LONG TERM CARE; LONGITUDINAL STUDY; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; TONIC CLONIC SEIZURE; BLOOD; COMPLICATION;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; EPILEPSY; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC;

EID: 85006173397     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316666961     Document Type: Short Survey

References (13)

1. Cimaz R, Taddio A, Systemic lupus erythematosus and other collagen vascular diseases. In: Shorvon SD, Anderman F, Guerriuni R, (eds). The causes of epilepsy, NY: Cambridge University Press, 2011, pp. 579-584.
2. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999; 42: 599-608.
3. Cimaz R, Guerrini R,. Epilepsy in lupus. Lupus 2008; 17: 777-779.
4. González-Duarte A, Cantú-Brito CG, Ruano-Calderón L, et al. Clinical description of seizures in patients with systemic lupus erythematosus. Eur Neurol 2008; 59: 320-323.
5. Andrade RM, Alarcón GS, González LA, et al. Seizures in patients with systemic lupus erythematosus: Data from LUMINA, a multiethnic cohort (LUMINA LIV). Ann Rheum Dis 2008; 67: 829-834.
6. Ramsey-Goldman R, Alarcón GS, McGwin G, et al. Time to seizure occurrence and damage in PROFILE, a multi-ethnic systemic lupus erythematosus cohort. Lupus 2008; 17: 177-184.
7. Hanly JG, Urowitz MB, Su L, et al. Seizure disorders in systemic lupus erythematosus results from an international, prospective, inception cohort study. Ann Rheum Dis 2012; 71: 1502-1509.
8. Hawro T, Bogucki A, Krupińska-Kun M, Maurer M, Woźniacka A,. Intractable headaches, ischemic stroke, and seizures are linked to the presence of anti-β2GPI antibodies in patients with systemic lupus erythematosus. PLoS One 2015; 10: e0119911-e0119911.
9. Liimatainen S, Peltola M, Fallah M, Kharazmi E, Haapala AM, Peltola J,. The high prevalence of antiphospholipid antibodies in refractory focal epilepsy is related to recurrent seizures. Eur J Neurol 2009; 16: 134-141.
10. Arinuma Y, Yanagida T, Hirohata S,. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2008; 58: 1130-1135.
11. Levite M, Ganor Y,. Autoantibodies to glutamate receptors can damage the brain in epilepsy, systemic lupus erythematosus and encephalitis. Expert Rev Neurother 2008; 8: 1141-1160.
12. Kampylafka EI, Alexopoulos H, Fouka P, Moutsopoulos HM, Dalakas MC, Tzioufas AG. Epileptic syndrome in systemic lupus erythematosus and neuronal autoantibody associations. Lupus 2016; 25: 1260-1265.
13. Gerosa M, Poletti B, Pregnolato F, et al. Antiglutamate receptor antibodies and cognitive impairment in primary antiphospholipid syndrome and systemic lupus erythematosus. Front Immunol 2016; 7: 5-5.